The key shift we need The question is no longer: Can patients stop GLP-1s without regaining weight? It is: Which patients can taper, how slowly, with what lifestyle support, and with what monitoring? Until trials are designed to study deprescribing strategies, weight regain after abrupt withdrawal should not be framed as inevitability
As a GLP-1 receptor agonist, Semaglutide enhances insulin secretion, reduces appetite, and improves energy utilization, making it a cornerstone therapy for type 2 diabetes and obesity
Weight loss medication is not a one-time prescription
Expert Medical Care Our qualified physicians and nurses conduct thorough medical evaluations that analyze the rate of weight loss, glucose tolerance/production, and more
Manufacturer: NOW FOODS 395 S